Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myelin and lymphocyte protein (MAL) is a highly hydrophobic, tetraspan integral membrane proteolipid that localizes to specialized membrane domains in T cells, polarized epithelial cells, and myelin-forming cells[1][2][4][5]. It is a member of the MARVEL domain family, involved in organizing and maintaining membrane microdomains important for vesicular trafficking, signal transduction, and myelin sheath maintenance[1][2]. In T cells, MAL is crucial for trafficking of key signaling molecules such as Lck kinase and is upregulated during Th2 differentiation in inflammatory or allergic responses[1]. In myelinating cells, it regulates lateral diffusion and membrane organization important for compact myelin formation and stability[1][5]. Its downregulation or epigenetic silencing is observed in various carcinomas, supporting a tumor suppressor role, while it also serves as a marker for primary mediastinal large B-cell lymphoma[3]. Although proposed as a receptor for Clostridium perfringens epsilon toxin, its prevailing biological roles are in membrane specialization and immune or neural development[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin and lymphocyte protein (MAL).